Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Primary versus recurrent surgery for glioblastoma-a prospective cohort study
FDA-approved branded medications through telehealth platforms with a membership-plus-medication model add a $39$149/month membership fee on top of the medication itself, with Wegovy or Zepbound retail running roughly $1,000$1,349/month before insurance though Lilly Direct's self-pay Zepbound vials brought the branded tirzepatide cash-pay price down to ~$499/month for eligible patients in 2026
Route changes are prescription-only and should be planned with your clinician
Look for those crucial codes: PA (Prior Authorization), ST (Step Therapy), QL (Quantity Limits)
Tanzilli G, Truscelli G, Arrivi A, et al
US$ 23.41
US$ 22.83
US$ 26.41
US$ 24.66
US$ 20.59
US$ 25.68
US$ 24.75
US$ 20.43
